• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[Evidence-based optimal treatment strategy of patients with angina pectoris].

作者信息

Jánosi András

机构信息

Fovárosi Onkormányzat Szent János Kórház-Rendelointézet III. Belgyógyászat, Kardiológia Budapest Diósárok út. 1. 1125.

出版信息

Orv Hetil. 2008 Feb 17;149(7):293-8. doi: 10.1556/OH.2008.28195.

DOI:10.1556/OH.2008.28195
PMID:18258559
Abstract

The author summarizes the evidences of angina pectoris' optimal treatment. The invasive treatment strategy became a frontrunner in this field as well. During the last years the number of percutaneous interventions became higher than bypass operations in many countries as well as in Hungary. The place of percutaneous interventions and bypass surgery in the treatment of angina pectoris is an important clinical problem. The author summarizes the data of three possible treatment options (medical therapy, percutaneous interventions and bypass surgery) of angina pectoris based on data of randomised trials. The evidences show that the first steps of therapy are - after the diagnosis - the influence of risk factors, life-style changes and optimal medical therapy. The optimal medical therapy consists of statin, aspirin and ACE inhibitor treatment besides antianginal therapy, where the beta blockers are regarded as first drugs of choice. Percutaneous interventions as initial treatment option are not recommended because we have no evidences that this intervention prolongs life and prevents myocardial infarction. If the patient remains symptomatic after medical treatment, it is necessary to perform revascularization. These procedures can improve the functional capacity more than medical treatment alone. The optimal treatment strategy of angina pectoris, based on evidence, is an important medical and economical problem.

摘要

相似文献

1
[Evidence-based optimal treatment strategy of patients with angina pectoris].
Orv Hetil. 2008 Feb 17;149(7):293-8. doi: 10.1556/OH.2008.28195.
2
[The evidence-based invasive therapy of stable angina pectoris].[稳定型心绞痛的循证侵入性治疗]
Orv Hetil. 2008 Feb 17;149(7):299-304. doi: 10.1556/OH.2008.28224.
3
[Treatment of stable angina pectoris. "Mother Courage and her children"].
Orv Hetil. 2008 Feb 17;149(7):291. doi: 10.1556/OH.2008.28317.
4
API expert consensus document on management of ischemic heart disease.缺血性心脏病管理的API专家共识文件
J Assoc Physicians India. 2006 Jun;54:469-80.
5
Effects of optimal medical treatment with or without coronary revascularization on angina and subsequent revascularizations in patients with type 2 diabetes mellitus and stable ischemic heart disease.最佳药物治疗联合或不联合冠状动脉血运重建对 2 型糖尿病合并稳定型缺血性心脏病患者心绞痛及后续血运重建的影响。
Circulation. 2011 Apr 12;123(14):1492-500. doi: 10.1161/CIRCULATIONAHA.110.978247. Epub 2011 Mar 28.
6
Ten-year outcomes of patients randomized to surgery, angioplasty, or medical treatment for stable multivessel coronary disease: effect of age in the Medicine, Angioplasty, or Surgery Study II trial.稳定多血管冠状动脉疾病患者随机接受手术、血管成形术或药物治疗的 10 年结果:Medicine, Angioplasty, or Surgery Study II 试验中年龄的影响。
J Thorac Cardiovasc Surg. 2013 Nov;146(5):1105-12. doi: 10.1016/j.jtcvs.2012.08.015. Epub 2012 Aug 31.
7
Clinical implications of the BARI 2D and COURAGE trials: the evolving role of percutaneous coronary intervention.BARI 2D和COURAGE试验的临床意义:经皮冠状动脉介入治疗的角色演变
Coron Artery Dis. 2010 Nov;21(7):397-401. doi: 10.1097/MCA.0b013e32833d0134.
8
Do differences in repeat revascularization explain the antianginal benefits of bypass surgery versus percutaneous coronary intervention?: implications for future treatment comparisons.再次血运重建的差异是否解释了搭桥手术与经皮冠状动脉介入治疗相比的抗心绞痛益处?对未来治疗比较的启示。
Circ Cardiovasc Qual Outcomes. 2012 May;5(3):267-75. doi: 10.1161/CIRCOUTCOMES.111.964585. Epub 2012 Apr 10.
9
The place of metabolic agents in the management of stable angina pectoris.
Rev Port Cardiol. 1999 Sep;18 Suppl 4:IV23-7.
10
Outcome in high risk patients with unprotected left main coronary artery stenosis treated with percutaneous coronary intervention.高危无保护左主干冠状动脉狭窄患者经皮冠状动脉介入治疗的结果。
Catheter Cardiovasc Interv. 2010 Jan 1;75(1):101-8. doi: 10.1002/ccd.22205.